All News

Bisphosphonate therapy for osteoporosis may increase the risk of serious atrial fibrillation, which can result in hospitalization or death, according to research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians, in Philadelphia.